sympathetic ganglia (I). In the 1950s, the collaboration between a great developmental biologist, Rita Levi-Montalcini, and a great biochemist, Stanley Cohen, resulted in the Nobel Prize-winning discovery, purification and biological characterization of the first defined growth factor, nerve growth factor (3) (4) (5) . Neurotrophin family includes NGF, which is important for survival of nociceptive neurons during development. NGF is a diffusible protein playing a crucial role in several organ functions and is a targetderived pro-survival factor for sensory and sympathetic neurons derived from ganglia isolated from chick embryos (4) . These studies conducted to the discovery of the other members of the mammalian neurotrophin (NT) family NT-3 and NT-4, together with their specific tropomyosin-related kinase (Trk) receptors TrkA, TrkB and TrkC as well as the panneurotrophin receptor p75 NTR (6) .
In addition, from the serendipitous observation that snake venom contained large quantities ofNGF, it became possible to purify the protein from mouse sub-maxillary glands. EGF was discovered unexpectedly from an assay of crude fractions of NGF that resulted in precocious opening of eyelids and keratinization of the skin (5) (6) . It is widely accepted that NGF and its receptors, TrkA and p75, become internalized and are retrogradedly transported to the cell body (Ye et ai, 2003) in "signaling endosomes" (7) . Nerve growth factor is widely recognized as an important factor responsible for the survival and maintenance of the phenotype of specific subsets of peripheral neurons and basal forebrain cholinergic nuclei during development and maturation.
The inflammatory response in immediate hypersensitivity reactions is in part mediated by the nervous system. In fact, this reaction is markedly diminished in tissues lacking innervations.
It is well known that the nervous system affects immediate hypersensitivity reactions and neuropeptides are involved. Therefore, several neuropeptides including substance P, somatostatin, vasoactive intestinal peptide, and NGF mediate neuroendocrine-linked mast cell activation (8) . Proteins, including cytokines produced in the brain may influence its development, differentiation and function in normal and pathological circumstances. In fact, cytokine generated by Th2 lymphocytes involved in allergic diseases have recently been implicated in several neurological diseases such as multiple sclerosis, brain metastases, and allergic encephalomyelitis, all mediated by mast cell products (9) .
NGF influences development, differentiation, chemotaxis and mediator release of inflammatory cells and the activation of fibroblasts through a complex mechanism(s) influenced by several proinflammatory cytokines (10) .
When the nerve fibers come into contact with neuropeptides, they react by swelling -an effect that yields headaches and sinus symptoms. Sensory neuropeptides may activate brain mast cells to release inflammatory mediators such as histamine, serotonin, arachidonic acid compound and de novo synthesized cytokines/chemokines ( 10) .
NGF is a neutrophin exerting an important role in the development and functions of the central and peripheral nervous system. NGF is a neuropeptide involved in neurogenic inflammation and most of its pathophysiological functions are mediated through binding to its receptor. It also exerts various proinflammatory actions on immunocells (B and T lynphocytes, mast cells, neutrophils, eosinophils) and structural cells (smooth muscles, fibroblasts, endothelial cells). Recently it has been reported by several authors that NGF promotes in vitro maturation of human cord blood-derived mast cells as evaluated by the expression of the a/~tryptase and chymase, and of the immature HMC-I line, and increases the survival of mast cells from rat peritoneal cavity in vitro by inhibiting their apoptosis (11) .
NGF exerts a modulatory role on sensory nociceptive nerve physiology in the adult, and appears to correlate with hyperalgesic phenomena occurring in tissue inflammation. In fact, NGF can thus be viewed as a multifactorial modulatcr of neuroimmune-endocrine functions.
The future goal ofNGF is to use it in the clinical trials for the treatment of Alzheimer's disease; however, nowadays it seems an impossible mission, since in this case millions of neurons are already killed both in neocortex and in the hippocampal system (12) . Therefore, only a treatment employing NGF could potentially repair the disrupted synaptic communication between neurons and eventually ameliorate the cognitive and behavioral disorders. In addition, the implantation of neural stem cells is thought to be a difficult task considering the complex architecture of neuronal networks and circuits in the affected areas. It has recently been documented that several immune cells, such as mast cells, lymphocytes and eosinophils, produce, store and release NGF (13) .
NGF is involved in the production of IgM, IgA (14) , and IgG4 antibodies, induction of high-affinity of interleukin(lL)-2 receptors on human peripheral blood mononuclear cells and promotion of human hemopoietic cell growth and proliferation (15) .
Mast cells
The first line of defense includes cellular barriers, such as the skin, the mucosal surfaces and the gastrointestinal and respiratory tracts. The immune system is composed by the innate and adaptive immunity that protect the body against intruding microbes. Innate immunity, which is a multi-component system, is the first line of defense against infections. It is phylogenetically the oldest mechanism of defense against microbes and is present in all multicellular organisms including plants. T and B lymphocytes which mediate the adaptive immune response are specific and temporally delayed responses after recognizing antigenic epitopes through specific recombined receptors. The innate immune system has the ability to stimulate and modulate adaptive immunity (16) .
Immune cells of the innate immune system, such as dendritic cells (DCs), macrophages, granulocytes, natural killer (NK) cells, monocytes, NKT cells, yo T cells, and mast cells, mediate fast but nonspecific responses after recognizing generic antigen through their receptors, including Toll-like receptors (17) .
Human mast cells develop from committed precursors in the bone marrow expressing the differentiation marker CD34 and distinct from the three other myeloid cells. MCs have long been known to participate in the inflammatory process and there is evidence that they orchestrate the inflammatory reactions. They are normally present in the brain, peritoneum, synovium, hair follicles, skin, gastrointestinal tract, airways, and many other organs, where they are in close contact with the outside environment. Mast cells can be activated to release potent mediators of inflammation by antibody-dependent mechanisms, and can respond to very low doses of specific antigen. Although mast cells have been known to amplify inflammatory responses to antigen challenge, however, the molecular mechanism(s) by which these cells induce increased vascular permeability remain to be elucidated. Mast cell mediators are either contained within secretory granules or can be synthesized de novo and can be released upon activation by either a massive degranulation, or by a selective release of specific molecules (16) .
Mast cells can be also activated by bacterial or viral antigens, cytokines, growth factors, and hormones, leading to differential release of distinct mediators without degranulation.
TH2 cytokines involved in allergic diseases have recently been implicated in several neurological diseases such as multiple sclerosis, brain metastases, allergic encephalomyelitis and allergic encephalomyelitis, all mediated by mast cell products. Mast cells are present in many epithelial and serosal cavities, and respond to microbes and various mediators by secreting molecules that stimulate inflammation. Mast cells are derived from progenitors in the bone marrow and are not found in the circulation, while they are found throughout the body, especially near blood vessels, epithelia and nerves. Mast cells are activated by cross-linking of FcRI molecules, which occurs by the binding of multivalent antigens to the attached IgE molecules. Mast cells produce NGF, suggesting that alterations in normal mast cell behaviour can provoke maladaptive neuroimmune tissue responses the consequences of which have profound implications in inflammatory diseases (18) . In fact, NGF mediates a number of inflammatory and autoimmune states in conjunction with an increased accumulation of mast cells which appear to be involved in neuroimmune interactions and tissue inflammation. In addition, mast cell mediators induce microvascular leakage and stimulate protease-activated receptors (PAR), leading to widespread brain inflammation. Brain diseases appear to worsen in response to acute stress that leads to the local release of cytokines such as TNF-alpha and vascular endothelial growth factor (VEGF) by mast cells, a phenomenon absent in WIW mast cell deficient mice (19) .
It has been reported that several mediators and receptors including NGF, neurotrophins, brain-derived neurotrophic factor, neurokininsl neuropeptides such as substance P, gastrin-releasing peptide, cytokines such as interleukin-31, autotaxin and the histamine H4 receptor may playa role in the pathophysiology of skin (20) .
Mast cells generate and release NGF after degranulation, which is involved in iperalgesia and plays an important role in sensitization through mast cell activation even though this mechanism(s) is not yet clear (21) . Mast cells were the first cells of immune lineage to be identified as a target for NGF, both in vivo and in vitro. Neonatal rats given daily injections of NGF showed a massive mast cell hyperplasia involving connective tissue mast cells in several peripheral tissues, an effect later extended also to mucosal mast cells (22) . Cytokine production by activated mast cells is a consequence of newly induced cytokine gene transcription which appears to be similar to the events that occurs in T cells. Cytokines produced in the brain may influence its development, differentiation and function in normal and pathological circumstances. In addition, anti-NGF antibodies reduce rat peritoneal mast-cell numbers (23) . Data suggest a specific and direct NGF effect on the differentiation and maturation of mast cells and/or their precursors, acting as a co-factor with IL-3. In inflammation and brain diseases mast cells and microglia produce and regulate TNF-alpha, an effect mediated by PKC-alpha-dependent pathway. The release ofTNF-alpha is also trigged via P2X7 receptor involving mitogen-activated protein (MAP) kinases, extra cellular receptor-activated kinase (ERK), and c-Jun N-terminal kinase (JNK). These transcription factors stimulate several cytokines and chemokines involved in brain inflammation (24) .
Moreover, NGF is a potent degranulating factor for mast cells in vitro cultured with phosphatidylserine and can induce mast cell-marker expression (25) .
In addition, it has been demonstrated that NGF levels are decreased in atherosclerotic coronary vascular tissue but increased in the subepicardial adipose tissue, whereas both tissues express a greater number of mast cells and a stronger p75 NTR immunoreactivity. In fact, metabolic syndrome patients display a significant hyponeurotrophinemia and an increased number of adipose mast cells (26) .
Taken together, these findings suggest that neuroimmune mediators NGF and other neuropeptides, acting on mast cells may be involved in the develop-ment of brain diseases and related disorders.
